Heterocyclyl-substituted anti-hypercholesterolemic compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/10 (2006.01) A61K 31/4178 (2006.01) A61K 31/4192 (2006.01) A61K 31/4196 (2006.01) A61K 31/422 (2006.01) A61K 31/427 (2006.01) A61K 31/495 (2006.01) A61K 31/497 (2006.01) A61K 31/541 (2006.01) A61P 9/10 (2006.01) C07D 403/10 (2006.01) C07D 413/10 (2006.01)

Patent

CA 2668371

This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts thereof, wherein R12 is a hydroxylated alkyl group and R9 contains a heterocyclic ring. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating atherosclerosis and preventing atherosclerotic disease events.

L'invention concerne des inhibiteurs de l'absorption du cholestérol de formule I : et ses sels pharmaceutiquement acceptables, R12 représentant un groupement alkyle hydroxylé et R9 contenant un cycle hétérocyclique. Les composés sont utiles pour l'abaissement des niveaux de cholestérol, notamment de cholestérol LDL, et pour le traitement de l'athérosclérose et la prévention des évènements athérosclérotiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclyl-substituted anti-hypercholesterolemic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclyl-substituted anti-hypercholesterolemic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyl-substituted anti-hypercholesterolemic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1892791

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.